A trial to study the place of surgery in elderly women with breast cancer treated by tamoxifen
| ISRCTN | ISRCTN72493595 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN72493595 |
| Protocol serial number | CRCBCTG6 |
| Sponsor | UK Co-ordinating Committee for Cancer Research (UKCCCR) |
| Funder | Not provided at time of registration |
- Submission date
- 01/07/2001
- Registration date
- 01/07/2001
- Last edited
- 13/06/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr - -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Breast |
| Intervention | 1. Group A: Optimal surgery plus tamoxifen, 20 mg twice daily 2. Group B: Tamoxifen, 20 mg twice daily All patients receive tamoxifen until there is evidence of progressive disease. |
| Intervention type | Other |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 31/12/1997 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Sex | Female |
| Key inclusion criteria | 1. Aged >70 years 2. Histological, cytological or unequivocal mammographic confirmation of carcinoma of the breast 3. Operable breast cancer 4. No metastases 5. No previous malignancy, except skin cancer or adequately treated in situ carcinoma of the cervix 6. Fit and willing to receive either treatment |
| Key exclusion criteria | 1. Patients with bilateral breast cancer are excluded 2. Patients with Paget's disease without a palpable lump, in situ carcinoma or an impalpable lesion shown on mammograph alone are excluded |
| Date of first enrolment | 01/01/1995 |
| Date of final enrolment | 31/12/1997 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/08/1997 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |